Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -7,907 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 110 | N/A | N/A | N/A |
| Other Working Capital | 768 | N/A | N/A | N/A |
| Other Operating Activity | 211 | 0 | 0 | 0 |
| Operating Cash Flow | $-6,818 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 7 | N/A | N/A | N/A |
| Other Financing Activity | 6,232 | 0 | 0 | 0 |
| Financing Cash Flow | $6,239 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 7,131 | N/A | N/A | N/A |
| End Cash Position | 6,552 | N/A | N/A | N/A |
| Net Cash Flow | $-579 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -6,818 | N/A | N/A | N/A |
| Free Cash Flow | -6,818 | 0 | 0 | 0 |